PAK3

Chr X

p21 (RAC1) activated kinase 3

Also known as: ARA, MRX30, MRX47, OPHN3, PAK-3, PAK3beta, XLID30, bPAK

The protein encoded by this gene is a serine-threonine kinase and forms an activated complex with GTP-bound RAS-like (P21), CDC2 and RAC1. This protein may be necessary for dendritic development and for the rapid cytoskeletal reorganization in dendritic spines associated with synaptic plasticity. Defects in this gene are the cause of a non-syndromic form of X-linked intellectual disability. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2017]

ResearchGenerating clinical summary…
MultiplemechanismLOEUF 0.29
Clinical SummaryPAK3
🧬
Gene-Disease Validity (ClinGen)
X-linked syndromic intellectual disability · XLDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.99). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
28 unique Pathogenic / Likely Pathogenic· 124 VUS of 296 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.29LOEUF
pLI 0.987
Z-score 3.95
OE 0.09 (0.040.29)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
3.53Z-score
OE missense 0.32 (0.260.39)
69 obs / 214.7 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.09 (0.040.29)
00.351.4
Missense OE?0.32 (0.260.39)
00.61.4
Synonymous OE?0.95
01.21.6
LoF obs/exp: 2 / 22.0Missense obs/exp: 69 / 214.7Syn Z: 0.32
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitivePAK3-related intellectual developmental disorderLOFXLR
definitivePAK3-related agenesis of the corpus callosumGOFXLR

This gene — mechanism propensity

DN
0.4884th %ile
GOF
0.6248th %ile
LOF
0.65top 25%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 57% of P/LP variants are LoF · LOEUF 0.29 · ClinGen HI: Sufficient evidence for dosage pathogenicity

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

296 submitted variants in ClinVar

Classification Summary

Pathogenic5
Likely Pathogenic23
VUS124
Likely Benign39
Benign33
Conflicting5
5
Pathogenic
23
Likely Pathogenic
124
VUS
39
Likely Benign
33
Benign
5
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
3
1
1
0
5
Likely Pathogenic
13
8
2
0
23
VUS
3
103
16
2
124
Likely Benign
0
7
11
21
39
Benign
0
0
25
8
33
Conflicting
5
Total191195531229

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

94 pathogenic / likely-pathogenic (of 104) ClinVar copy-number / structural variants overlap PAK3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PAK3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.